Poikiloderma with Neutropenia, Clericuzio Type (OMIM #604173): From USB1 RNA Biology to a Candidate Model of Compartmentalized Cyclic Nucleotide Signaling
Genes · 07.11.2026 · 17 (11) · 1401
DOI: 10.3390/genes17111401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 07.11.2026. Verfasst von Yaddanapudi Ravindranath und 8 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Poikiloderma with neutropenia, Clericuzio type (PN; OMIM #604173), is a rare autosomal recessive genodermatosis caused by biallelic loss-of-function variants in U6 snRNA Biogenesis 1 (USB1), with approximately 100 molecularly confirmed cases. Beyond the defining post-inflammatory poikiloderma and non-cyclic neutropenia, affected individuals show recurrent sinopulmonary infection, impaired wound healing, tendon contractures, and primary gonadal failure in males. USB1 is a 2H-superfamily 3′ to 5′ exoribonuclease that removes oligoadenylate tails added by Poly(A) polymerase associated protein 5 (PAPD5) and PAPD7; its loss destabilizes guide-strand microRNAs and blocks the emergence of CD45+ hematopoietic progenitors. Splicing is not measurably disturbed in patient cells, so the earlier splicing-centered account requires revision. Drawing on previously unpublished endocrine, neurologic and imaging data from two affected brothers, we develop a candidate model in which the microRNA lesion reaches cyclic nucleotide signaling by two routes: de-repression of phosphodiesterase E3B (PDE3B) after loss of miR-142-5p, and loss of a perinuclear and Golgi cyclic AMP compartment after coordinate reduction in A-kinase anchoring protein 6 (AKAP6) and PDE4D interacting protein (PDE4DIP). We state where the model is supported, where it conflicts with published effects, and what would refute it, arguing for compartment-restricted dysregulation rather than global deficiency. PAPD5/7 inhibition, leading to repression of PDE3B, is closest to the causal lesion, but its on-target neurotoxicity makes it an experimental tool rather than a candidate drug.
Zitieren
APA
Ravindranath, Y., Huq, A. H. M. M., Novice, M., Grover, S. K., Lakshmanan, Y., Chu, R., Martin, A., Potts, G., & Parajuli, P. (2026). Poikiloderma with Neutropenia, Clericuzio Type (OMIM #604173): From USB1 RNA Biology to a Candidate Model of Compartmentalized Cyclic Nucleotide Signaling. Genes, 17(11), 1401. https://doi.org/10.3390/genes17111401
Vancouver
Ravindranath Y, Huq AHMM, Novice M, Grover SK, Lakshmanan Y, Chu R, et al. Poikiloderma with Neutropenia, Clericuzio Type (OMIM #604173): From USB1 RNA Biology to a Candidate Model of Compartmentalized Cyclic Nucleotide Signaling. Genes. 2026;17(11):1401. doi:10.3390/genes17111401
BibTeX
@article{Ravindranath2026,
author = {Ravindranath, Yaddanapudi and Huq, A. H. M. Mahbubul and Novice, Madison and Grover, Sudershan Kumar and Lakshmanan, Yegappan and Chu, Roland and Martin, Alissa and Potts, Geoffrey and Parajuli, Prahlad},
title = {Poikiloderma with Neutropenia, Clericuzio Type (OMIM #604173): From USB1 RNA Biology to a Candidate Model of Compartmentalized Cyclic Nucleotide Signaling},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1401},
doi = {10.3390/genes17111401}
}
EUVIMED